CAN HEPATITIS C VIRUS PREVALENCE BE USED AS A MEASURE OF INJECTION-RELATED HUMAN IMMUNODEFICIENCY VIRUS RISK IN POPULATIONS OF INJECTING DRUG USERS?. AN ECOLOGICAL ANALYSIS
Guardat en:
VICKERMAN, P., ET AL., CAN HEPATITIS C VIRUS PREVALENCE BE USED AS A MEASURE OF INJECTION-RELATED HUMAN IMMUNODEFICIENCY VIRUS RISK IN POPULATIONS OF INJECTING DRUG USERS?. AN ECOLOGICAL ANALYSIS. ADDICTION, Vol. 105, no. 2 (2010), p. 311-318.
Ref.
165038
Localització:
SIIS R.696 Archivo
Palabras clave:
Detección, Discapacidad, Drogas ilegales, Drogodependencias, Evaluación, Hepatitis, Riesgo, Sida, Vía intravenosa
Detección, Discapacidad, Drogas ilegales, Drogodependencias, Evaluación, Hepatitis, Riesgo, Sida, Vía intravenosa
Ítems similars: CAN HEPATITIS C VIRUS PREVALENCE BE USED AS A MEASURE OF INJECTION-RELATED HUMAN IMMUNODEFICIENCY VIRUS RISK IN POPULATIONS OF INJECTING DRUG USERS?. AN ECOLOGICAL ANALYSIS
- THE IMPACT OF BEHAVIOURAL CHANGES ON THE PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS C AMONG INJECTING DRUG USERS
- The effect of hepatitis C treatment and human immunodeficiency virus (VIH) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam
- HEPATITIS C VIRUS TRANSMISSION DYNAMICS IN INJECTION DRUG USERS
- HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS C VIRUS TESTING SERVICES AT SYRINGE EXCHANGE PROGRAMS: AVAILABILITY AND OUTCOMES
- EVIDENCE FOR THE EFFECTIVENESS OF STERILE INJECTING EQUIPMENT PROVISION IN PREVENTING HEPATITIS C AND HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION AMONG INJECTING DRUG USERS: A REVIEW OF REVIEWS
- Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus